
|Articles|October 1, 2001
Farewell to the politics of surplus
Federal government's budget situation.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Payer Implications and Final Takeaways from the BE BOLD Trial
2
A conversation with Tiffany Phung, Pharm.D., CSP, about how patient outcomes drive specialty pharmacy strategy
3
The biosimilars market is projected to nearly double — here's where the growth is coming from
4
Journavx helped most patients avoid opioids after surgery, a recent study found
5






















